Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy.
Aged
Case-Control Studies
Choroid
/ blood supply
Choroid Diseases
/ diagnosis
Coloring Agents
/ pharmacology
Female
Fluorescein Angiography
/ methods
Follow-Up Studies
Humans
Indocyanine Green
/ pharmacology
Male
Middle Aged
Polyps
/ diagnosis
Retinal Vessels
/ abnormalities
Retrospective Studies
Tomography, Optical Coherence
/ methods
Visual Acuity
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
21
7
2021
Statut:
ppublish
Résumé
To evaluate vortex vein engorgement and choroidal vascular hyperpermeability in patients with polypoidal choroidal vasculopathy (PCV) using ultra-widefield indocyanine green angiography (ICGA). This retrospective case control study included 51 patients with unilateral PCV, 7 patients with bilateral PCV, and 43 age-matched controls. The number of quadrants of vortex vein engorgement was evaluated in the middle phase of ICGA, which was classified as extended engorgement if the dilated choroidal vessels expanded to the macula. The area of choroidal vascular hyperpermeability was quantified stereographically from the late-phase ICGA and correlated with clinical and optical coherence tomography findings. Affected eyes had a larger choroidal hyperpermeability area and a thicker subfoveal choroid than eyes in the control group or fellow eyes (P < 0.001, P < 0.001). More quadrants with extended vortex vein engorgement were observed in affected eyes than in fellow eyes (P < 0.001). Significant differences were observed in the area of choroidal hyperpermeability, Haller layer thickness and greatest linear dimension according to the extended vortex vein engorgement in eyes with PCV (P < 0.001, P = 0.001, and P = 0.001, respectively). The area of choroidal hyperpermeability was significantly correlated with subfoveal choroidal thickness (P < 0.001, Pearson's correlation coefficient = 0.471). Ultra-widefield ICGA results revealed that patients with PCV had vortex vein engorgement and an increased choroidal hyperpermeability area. The results from this study provide substantial information to clarify the pathogenesis and predict the prognosis in the patients with PCV.
Identifiants
pubmed: 33605985
pii: 2772308
doi: 10.1167/iovs.62.2.29
pmc: PMC7900872
doi:
Substances chimiques
Coloring Agents
0
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
29Références
Retina. 2015 Jan;35(1):1-9
pubmed: 25158945
Arch Ophthalmol. 2003 Oct;121(10):1392-6
pubmed: 14557174
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3663-72
pubmed: 22570352
Invest Ophthalmol Vis Sci. 2014 Apr 29;55(5):3223-30
pubmed: 24781946
Middle East Afr J Ophthalmol. 2008 Apr;15(2):90-3
pubmed: 21346845
Am J Pathol. 2017 Dec;187(12):2841-2857
pubmed: 28941979
Retina. 2013 Sep;33(8):1659-72
pubmed: 23751942
Ophthalmic Surg Lasers Imaging. 2009 Nov-Dec;40(6):576-81
pubmed: 19928723
Retina. 2016 Mar;36(3):499-516
pubmed: 26335436
Ophthalmology. 2015 Apr;122(4):864-6
pubmed: 25576995
Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2309-2317
pubmed: 30259090
Am J Ophthalmol. 2002 May;133(5):639-48
pubmed: 11992861
PLoS One. 2016 Jan 22;11(1):e0147346
pubmed: 26799405
Eye (Lond). 2013 Sep;27(9):1038-43
pubmed: 23764988
Retina. 2016 Dec;36 Suppl 1:S73-S82
pubmed: 28005665
Eye (Lond). 2010 Mar;24(3):483-90
pubmed: 20075967
Retina. 2013 Apr;33(4):834-40
pubmed: 23117282
Br J Ophthalmol. 2002 Oct;86(10):1093-8
pubmed: 12234885
Ophthalmology. 2011 May;118(5):840-5
pubmed: 21211846
Retina. 2020 Mar;40(3):477-489
pubmed: 30475788
Retina. 2013 Jan;33(1):48-55
pubmed: 22836900
Ophthalmol Retina. 2018 Apr;2(4):295-305
pubmed: 31047238
Am J Ophthalmol. 2013 Dec;156(6):1192-1200.e1
pubmed: 24011522
Retina. 2020 Oct;40(10):1851-1864
pubmed: 32740492
Surv Ophthalmol. 2010 Nov-Dec;55(6):501-15
pubmed: 20850857
Jpn J Ophthalmol. 2008 Jan-Feb;52(1):57-62
pubmed: 18369702
Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1123-8
pubmed: 21274555
Invest Ophthalmol Vis Sci. 2015 Feb 26;56(3):1909-15
pubmed: 25722216
BMC Ophthalmol. 2013 Aug 20;13:43
pubmed: 23962072
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4729-37
pubmed: 18586873
Retina. 1999;19(6):508-12
pubmed: 10606450
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4982-91
pubmed: 19357355
Am J Ophthalmol. 2014 Aug;158(2):362-371.e2
pubmed: 24794091
Retina. 2016 Jan;36(1):1-8
pubmed: 26414957
Eye (Lond). 2019 Jan;33(1):14-33
pubmed: 29995841
Am J Ophthalmol. 2013 Feb;155(2):305-313.e1
pubmed: 23022162
Retina. 2012 Feb;32 Suppl 1:1-8
pubmed: 22451948
Am J Ophthalmol. 2006 Oct;142(4):601-7
pubmed: 17011852
Retina. 2011 Oct;31(9):1904-11
pubmed: 21878855
PLoS One. 2015 Mar 16;10(3):e0120643
pubmed: 25775011